Published in Circulation on August 01, 1995
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging (2008) 1.52
Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci U S A (2006) 0.95
Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci U S A (1998) 0.82
Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Eur J Nucl Med Mol Imaging (2003) 0.78
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A (1998) 7.78
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res (1995) 6.21
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci U S A (1981) 3.63
Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science (2000) 2.82
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem (2006) 2.58
Incidence of human immunodeficiency virus among male-to-female transgendered persons in San Francisco. J Acquir Immune Defic Syndr (2001) 2.47
Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect (2006) 2.45
Quo vadis radioimmune imaging. J Nucl Med (1989) 2.33
Vagal non-adrenergic inhibition of guinea-pig stomach. J Physiol (1971) 2.29
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco. J Acquir Immune Defic Syndr (1999) 2.28
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization. Proc Natl Acad Sci U S A (1978) 2.06
Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab (1999) 2.04
Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim Biophys Acta (1991) 2.01
Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res (1999) 2.00
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 1.94
p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. Biochim Biophys Acta (2001) 1.82
The effect of catecholamines and sympathetic stimulation on the release of acetylcholine from the guinea-pig colon. Br J Pharmacol (1969) 1.81
111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med (1989) 1.76
Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods (1986) 1.73
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun (1999) 1.70
Immunologic phenotype in 30 patients with diffuse large-cell lymphoma. N Engl J Med (1980) 1.68
Vascular permeability in a human tumour xenograft: molecular charge dependence. Br J Cancer (2000) 1.60
Laparoscopic cholecystectomy in the third trimester of pregnancy. Am Surg (1996) 1.60
Intestinal perforation as a long-term complication of plug and mesh inguinal hernioplasty: case report. Hernia (2004) 1.58
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58
Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol (1990) 1.55
A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology (1998) 1.52
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest (1993) 1.46
Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med (1991) 1.45
Allergic vasculitis Gougerot-Ruiter syndrome. Arch Dermatol (1967) 1.44
Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res (1998) 1.44
In vivo uptake of radiolabeled antibody to proliferating smooth muscle cells in a swine model of coronary stent restenosis. J Nucl Med (2000) 1.43
Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol (1999) 1.43
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization. J Nucl Cardiol (1996) 1.41
TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother (2000) 1.41
Cardiac sarcoplasmic reticulum calcium ATPase, an autoimmune antigen in experimental cardiomyopathy. Circulation (1994) 1.40
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting. J Nucl Cardiol (1997) 1.37
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Maturation of B lymphocytes in the rat. I. Migration pattern, tissue distribution, and turnover rate of unprimed and primed B lymphocytes involved in the adoptive antidinitrophenyl response. J Exp Med (1973) 1.34
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol Med (1995) 1.34
A single monoclonal antibody identifies T-cell lineage of childhood lymphoid malignancies. Blood (1983) 1.32
Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30
Echocardiographic evaluation of patients with acute rheumatic fever and rheumatic carditis. Circulation (1996) 1.28
Localization of cardiac myosin-specific antibody in myocardial infarction. J Clin Invest (1976) 1.27
Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26
Further evidence for the presence of non-adrenergic inhibitory structures in the guinea-pig colon. Eur J Pharmacol (1968) 1.26
Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology (1992) 1.25
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. Cancer Res (2001) 1.24
Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report. Pediatrics (2001) 1.24
Pan-leukocyte monoclonal antibody L3B12. Characterization and application to research and diagnostic problems. Am J Clin Pathol (1984) 1.24
Alternative promoter and 5' exon generate a novel Gs alpha mRNA. J Biol Chem (1990) 1.23
Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J (1974) 1.22
Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol (1996) 1.22
Quantitation of DNA fragmentation in apoptosis. Nucleic Acids Res (1996) 1.22
Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis (1990) 1.20
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Murine model of accelerated transplant arteriosclerosis. Circ Res (1994) 1.18
Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs. Eur J Pharmacol (1970) 1.16
Percutaneous endovascular abdominal aortic aneurysm repair: methods and initial outcomes from the first prospective, multicenter trial. J Cardiovasc Surg (Torino) (2011) 1.16
Bowel frequency in healthy children. Acta Paediatr Scand (1989) 1.16
The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. Eur J Cancer (2000) 1.15
Human normal and leukemia cell surface antigens. Mouse monoclonal antibodies as probes. Curr Top Microbiol Immunol (1978) 1.14
A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr (2001) 1.13
Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid. Science (1980) 1.11
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem (1999) 1.11
Physical and enzymatic properties of a class II alcohol dehydrogenase isozyme of human liver: pi-ADH. Biochemistry (1984) 1.11
Biological characteristics of T and B memory lymphocytes in the rat. J Exp Med (1973) 1.10
Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett (1991) 1.10
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Clinical and socio-economic impact of influenza and respiratory syncytial virus infection on healthy children and their households. Clin Microbiol Infect (2005) 1.07
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med (1975) 1.06
A novel class of antitumor antibodies: nucleosome-restricted antinuclear autoantibodies (ANA) from healthy aged nonautoimmune mice. Oncol Res (1997) 1.06
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem (1997) 1.05
Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase. J Surg Res (2000) 1.04
Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry (1996) 1.04
The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups. Int J Neuropharmacol (1968) 1.03
Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrob Agents (2001) 1.03
Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation (1979) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'. Biochim Biophys Acta (1992) 1.02
Exenatide: a review from pharmacology to clinical practice. Diabetes Obes Metab (2009) 1.02
Liposomes as targetable drug carriers. Crit Rev Ther Drug Carrier Syst (1985) 1.01
Nodular vasculitis: immunofluorescent study; 7S gamma-globulin and complement (beta-1c-globulin) in lesions of nodular vasculitis. J Invest Dermatol (1966) 1.01
Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies. Cancer Detect Prev (1998) 1.01
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. Am J Cardiol (1984) 1.00
The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts. Cancer Res (1999) 0.99
Ring chromosome and latent centromeres. Cytogenet Cell Genet (1980) 0.99